0001641489-24-000051.txt : 20240627 0001641489-24-000051.hdr.sgml : 20240627 20240627164022 ACCESSION NUMBER: 0001641489-24-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240625 FILED AS OF DATE: 20240627 DATE AS OF CHANGE: 20240627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K CENTRAL INDEX KEY: 0001238403 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37524 FILM NUMBER: 241079836 MAIL ADDRESS: STREET 1: MYRIAD GENETICS STREET 2: 322 NORTH 2200 WEST CITY: SALT LAKE CITY STATE: UT ZIP: 84116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: vTv Therapeutics Inc. CENTRAL INDEX KEY: 0001641489 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473916571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3980 PREMIER DR STREET 2: SUITE 310 CITY: HIGH POINT STATE: NC ZIP: 27265 BUSINESS PHONE: 336-841-0300 MAIL ADDRESS: STREET 1: 3980 PREMIER DR STREET 2: SUITE 310 CITY: HIGH POINT STATE: NC ZIP: 27265 FORMER COMPANY: FORMER CONFORMED NAME: VTV Therapeutics Inc. DATE OF NAME CHANGE: 20150506 4 1 wk-form4_1719520815.xml FORM 4 X0508 4 2024-06-25 0 0001641489 vTv Therapeutics Inc. VTVT 0001238403 SPIEGELMAN DANIEL K C/O VTV THERAPEUTICS INC. 3980 PREMIER DRIVE, SUITE 310 HIGH POINT NC 27265 1 0 0 0 0 Director stock option (right to buy) 17.22 2024-06-25 4 A 0 6000 17.22 A 2034-06-25 Class A Common Stock 6000 6000 D The options will vest monthly over the three year period following date of grant. /s/ Paul J. Sekhri as Attorney-in-Fact 2024-06-27